Abstract
Severe aortic stenosis (sAS) is a relentless disease, which carries significant morbidity and mortality. Definitive treatment of sAS in the form of aortic valve replacement (AVR) mostly revolves around the presence of symptoms. Last decade has witnessed a surge in observational data suggesting asymptomatic sAS associated with higher cardiovascular events than what was previously appreciated. While society guidelines endorse early AVR in a selected subgroup of asymptomatic sAS patients, the majority are still managed with traditional “watchful-waiting” approach. This article reviews the available literature on the natural history of asymptomatic sAS, associated risk modifiers, and identify patients who are at high-risk for future clinical events to offer them preemptive valve placement therapy.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
